
Job Overview
Location
Remote - United Kingdom
Job Type
Full-time
Category
HR & Recruiting
Date Posted
June 20, 2026
Full Job Description
đź“‹ Description
- • Build our future together as a Senior Manager, Field Medical Affairs, Haemato-Oncology at Regeneron Pharmaceuticals, Inc., supporting national field engagement across haematological malignancies by exchanging scientific and medical information with key opinion leaders, healthcare professionals, researchers, and population-based decision makers.
- • Day to day, you will build peer relationships with key opinion leaders in haematological malignancies, act as a clinical and scientific resource for healthcare professionals, support company-sponsored clinical trials including investigator selection and enrolment, collaborate with Clinical Development and trial teams to execute medical plans, identify medical insights and research gaps, present scientific and clinical data in response to information requests, communicate complex data clearly to varied audiences, and balance field work, projects, and changing priorities with sound judgement.
- • You will join Regeneron’s UK Medical Affairs team, a science-driven organisation committed to developing life-changing medicines for serious diseases, where you will contribute to a fast-growing organisation making a meaningful difference to patients worldwide through innovative science and patient-focused medical strategy.
- • In this role, you can deepen your expertise in haemato-oncology, strengthen your ability to translate complex science into actionable insights, expand your network with leading investigators and institutions, and grow your impact in shaping medical strategy and supporting clinical advancement in lymphoma and multiple myeloma.
🎯 Requirements
- • Bachelor’s degree (preferably in a science-related field) and 4+ years of relevant experience, including 2+ years as a Medical Science Liaison in biotech or pharmaceutical oncology/haematology.
- • Knowledge or experience in the oncology/haematology therapeutic area.
- • Understanding of treatment guidelines, clinical research processes, European Union regulations, and compliant pharmaceutical practices.
- • Established relationships with key opinion leaders in malignant haematology and knowledge of relevant institutions.
- • Experience in lymphoma and/or multiple myeloma (preferred).
- • Drug launch experience (preferred).
🏖️ Benefits
- • Competitive and comprehensive total rewards package including annual bonuses or other incentive plans.
- • Equity awards as part of long-term compensation.
- • Pension or retirement benefits and 401(k) company match (where applicable).
- • Health and wellness programs, fitness centers, and insurance benefits (medical, dental, vision, life, and disability).
- • Paid time off and family support benefits.
- • Reasonable accommodation for applicants with known disabilities or chronic illnesses during recruitment.
Skills & Technologies
See exactly how your profile matches this role — strengths, skill gaps, and what to do about them.
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a biotechnology company that develops, manufactures and markets antibody-based medicines for ophthalmology, oncology, immunology, infectious disease and rare disorders. Founded in 1988 and headquartered in Tarrytown, New York, Regeneron uses its proprietary VelociSuite technologies to discover fully human monoclonal antibodies and other therapeutic proteins. Its FDA-approved products include EYLEA, Dupixent, Libtayo, Praluent and Kevzara, while a broad pipeline addresses asthma, cancer, Ebola, COVID-19 and other diseases. The company operates research, manufacturing and clinical facilities across the United States and collaborates with Sanofi, Bayer and other partners worldwide.
Subscribe to the weekly newsletter for similar remote roles and curated hiring updates.
Newsletter
Weekly remote jobs and featured talent.
No spam. Only curated remote roles and product updates. You can unsubscribe anytime.
Similar Opportunities

Airwallex (UK) Limited
1 month ago

Biogen, Inc.
3 months ago

Castai Group Inc.
3 months ago

Ensemble Health Partners LLC
2 months ago